| Year |
Citation |
Score |
| 2020 |
Melnyk JE, Steri V, Nguyen HG, Hann B, Feng FY, Shokat KM. The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells. Bioorganic & Medicinal Chemistry. 28: 115712. PMID 33069070 DOI: 10.1016/J.Bmc.2020.115712 |
0.351 |
|
| 2020 |
de la Calle CM, Fasulo V, Cowan JE, Lonergan PE, Maggi M, Gadzinski AJ, Yeung RA, Saita A, Cooperberg MR, Shinohara K, Carroll PR, Nguyen HG. Clinical Utility of 4Kscore, ExosomeDx and Magnetic Resonance Imaging for the Early Detection of High-Grade Prostate Cancer. The Journal of Urology. 101097JU000000000000. PMID 32897802 DOI: 10.1097/Ju.0000000000001361 |
0.36 |
|
| 2020 |
Herlemann A, Overland MR, Washington SL, Cowan JE, Westphalen AC, Carroll PR, Nguyen HG, Shinohara K, Cooperberg MR. How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound? European Urology Focus. PMID 32868222 DOI: 10.1016/J.Euf.2020.08.003 |
0.365 |
|
| 2020 |
Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer. The Journal of Urology. 101097JU000000000000. PMID 32519915 DOI: 10.1097/Ju.0000000000001186 |
0.381 |
|
| 2020 |
Washington SL, Baskin AS, Ameli N, Nguyen HG, Westphalen AC, Shinohara K, Carroll PR. MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort. Ajr. American Journal of Roentgenology. 1-5. PMID 31913068 DOI: 10.2214/Ajr.19.21559 |
0.352 |
|
| 2020 |
Lonergan PE, Washington SL, Cowan JE, Nguyen H, Cooperberg MR, Carroll P. Natural history of an immediately detectable PSA following radical prostatectomy: A description of a contemporary cohort. Journal of Clinical Oncology. 38: 356-356. DOI: 10.1200/Jco.2020.38.6_Suppl.356 |
0.371 |
|
| 2020 |
Lonergan PE, Washington SL, Zhao S, Cowan JE, Nguyen H, Shinohara K, Cooperberg MR, Carroll P. Risk factors which predict biopsy upgrading over time in active surveillance for prostate cancer. Journal of Clinical Oncology. 38: 290-290. DOI: 10.1200/Jco.2020.38.6_Suppl.290 |
0.378 |
|
| 2020 |
Calle Cdl, Fasulo V, Cowan J, Herlemann A, Chu C, Gadzinski A, Yeung RA, Saita A, Cooperberg M, Shinohara K, Carroll P, Nguyen H. Mp75-15 Evaluation Of The 4K Score And Mri For The Detection Of High-Grade Prostate Cancer The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000961.015 |
0.362 |
|
| 2020 |
Calle Cdl, Fasulo V, Cowan J, Herlemann A, Chu C, Gadzinski A, Yeung RA, Rozzano AS, Cooperberg M, Shinohara K, Carroll P, Nguyen H. Pd53-02 Clinical Utility Of Biomarkers 4K Score, Selectmdx And Exodx With Mri For The Detection Of High-Grade Prostate Cancer The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000955.02 |
0.345 |
|
| 2020 |
Washington S, Cowan J, Herlemann A, Zuniga K, Masic S, Nguyen H, Carroll P. Mp67-06 Influence Of Node-Positive Disease After Radical Prostatectomy On Biochemical Recurrence And Early Oncologic Outcomes In Men With Prostate Cancer The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000947.06 |
0.362 |
|
| 2019 |
Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M, Hope TA, Carroll PR, et al. Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer. European Urology Oncology. PMID 31411984 DOI: 10.1016/J.Euo.2018.11.002 |
0.375 |
|
| 2019 |
Westphalen AC, Fazel F, Nguyen H, Cabarrus M, Hanley-Knutson K, Shinohara K, Carroll PR. Detection of clinically signifi cant prostate cancer with PIRADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions. International Braz J Urol : Official Journal of the Brazilian Society of Urology. 45. PMID 31136112 DOI: 10.1590/S1677-5538.Ibju.2018.0768 |
0.336 |
|
| 2019 |
Balakrishnan AS, Cowan JE, Cooperberg MR, Shinohara K, Nguyen HG, Carroll PR. Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance. The Journal of Urology. 101097JU000000000000. PMID 30958738 DOI: 10.1097/Ju.0000000000000247 |
0.331 |
|
| 2019 |
Boreta L, Gadzinski AJ, Wu SY, Xu M, Greene K, Quanstrom K, Nguyen HG, Carroll PR, Hope TA, Feng FY. Location of recurrence by Gallium-68 PSMA-11 PET scan in prostate cancer patients eligible for salvage radiotherapy. Urology. PMID 30928607 DOI: 10.1016/J.Urology.2018.12.055 |
0.377 |
|
| 2019 |
Bancroft Brown J, Sriram R, VanCriekinge M, Delos Santos R, Sun J, Delos Santos J, Tabatabai ZL, Shinohara K, Nguyen H, Peehl DM, Kurhanewicz J. NMR quantification of lactate production and efflux and glutamate fractional enrichment in living human prostate biopsies cultured with [1,6- C ]glucose. Magnetic Resonance in Medicine. PMID 30924180 DOI: 10.1002/Mrm.27739 |
0.36 |
|
| 2019 |
Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD, Ilhan H, Wetter A, Rischpler C, et al. Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial. Jama Oncology. PMID 30920593 DOI: 10.1001/Jamaoncol.2019.0096 |
0.352 |
|
| 2019 |
Xu Y, Poggio M, Jin HY, Shi Z, Forester CM, Wang Y, Stumpf CR, Xue L, Devericks E, So L, Nguyen HG, Griselin A, Gordan JD, Umetsu SE, Reich SH, et al. Translation control of the immune checkpoint in cancer and its therapeutic targeting. Nature Medicine. PMID 30643286 DOI: 10.1038/S41591-018-0321-2 |
0.314 |
|
| 2019 |
Herlemann A, Cooperberg MR, Overland MR, Cowan JE, Washington SL, Carroll PR, Nguyen HG, Shinohara K. Mp30-10 Comparison Of Trus-Targeted Vs. Mri-Targeted Vs. Systematic Prostate Biopsy In Detecting Prostate Cancer The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557565.43479.5D |
0.357 |
|
| 2019 |
Ellis WJ, Donnelly BJ, Gorin MA, Pouliot F, Nguyen HG, Carroll PR, Scherr D, Probst S, Saperstein L, Fleshner N, Maroni P, Shah K, Stambler N, DiPippo VA, Strack T, et al. Pd60-11 A Phase 3 Study To Evaluate The Safety And Efficacy Of 99M Tc-Mip-1404 Spect/Ct Imaging To Detect Clinically Significant Prostate Cancer In Men With Biopsy Proven Low Grade Prostate Cancer Who Are Candidates For Active Surveillance (Prospect-As) The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557222.99762.6B |
0.377 |
|
| 2019 |
Nguyen HG, Schmidt* B, Hosseini-Asl E, So C, Socher R, Xiong C, Xue L, Carroll PR, Cooperberg MR. MP28-01 ARTIFICIAL INTELLIGENCE (AI) ACCURATELY AUTOMATE AND SPEED IMMUNOFLUORESCENCE (IF)-BASED DISCOVERY AND VALIDATION OF NOVEL PROGNOSTIC AND PREDICTIVE BIOMARKERS IN PROSTATE CANCER Journal of Urology. 201. DOI: 10.1097/01.Ju.0000555706.15264.Bf |
0.323 |
|
| 2018 |
Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer. European Urology Oncology. 1: 386-394. PMID 31158077 DOI: 10.1016/J.Euo.2018.04.018 |
0.392 |
|
| 2018 |
Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach Iii M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA. Impact of staging Ga-PSMA-11 PET scans on radiation treatment plans in patients with prostate cancer. Urology. PMID 30580002 DOI: 10.1016/J.Urology.2018.09.038 |
0.345 |
|
| 2018 |
Behr SC, Aggarwal R, Van Brocklin HF, Flavell RR, Geo K, Small EJ, Blecha J, Jivan S, Hope TA, Simko JP, Kurhanewicz J, Noworolski SM, Korn NJ, De Los Santos R, Cooperberg MR, ... ... Nguyen HG, et al. First-in-Human Phase I study of CTT1057, a Novel F Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate Specific Membrane Antigen in Prostate Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30464040 DOI: 10.2967/Jnumed.118.220715 |
0.373 |
|
| 2018 |
Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, Carroll PR, Hope TA. Diagnostic Accuracy of Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer. Radiology. 180788. PMID 30226456 DOI: 10.1148/Radiol.2018180788 |
0.346 |
|
| 2018 |
Leapman MS, Nguyen HG, Cowan JE, Xue L, Stohr B, Simko J, Cooperberg MR, Carroll PR. Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy. European Urology. PMID 30181067 DOI: 10.1016/J.Eururo.2018.08.020 |
0.381 |
|
| 2018 |
Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, et al. Development of a stress response therapy targeting aggressive prostate cancer. Science Translational Medicine. 10. PMID 29720449 DOI: 10.1126/Scitranslmed.Aar2036 |
0.384 |
|
| 2018 |
Gadzinski A, Nguyen H, Ameli N, Refaai K, Shinohara K, Wang H, Cedars B, Kornberg Z, Carroll P. Mp82-20 Improving The Detection Of High-Grade Prostate Cancer With Multiparametric Mri And The Kallikrein Panel The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.2748 |
0.382 |
|
| 2018 |
Garcia-Reyes K, Nguyen HG, Zagoria RJ, Shinohara K, Carroll PR, Behr SC, Westphalen AC. Mp57-11 Impact Of Lesion Visibility On Transrectal Ultrasound On The Prediction Of Clinically Significant Prostate Cancer (Gleason Score = 3+4) With Trus-Mri Fusion Biopsy The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1823 |
0.306 |
|
| 2018 |
Masic S, Nguyen H, Cowan J, Leapman M, Carroll P. Pd38-10 Impact Of Lymph Node Count And Adjuvant Therapy On Oncologic Outcomes In Node Positive Patients With Prostate Cancer The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1757 |
0.304 |
|
| 2018 |
Xu MJ, Kornberg Z, Gadzinski A, Diao D, Cowan J, Wu SY, Boreta L, Spratt DE, Nguyen H, Roach M, Hope T, Carroll P, Feng FY. Employing Molecular Imaging to Understand Tumor Genetic Risk Scores: PSMA Nodal Involvement Associated with High-Risk Decipher in Prostate Cancer International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.019 |
0.345 |
|
| 2018 |
Wu SY, Boreta L, Shinohara K, Nguyen H, Carroll P, Westphalen A, Hope T, Chang AJ. (OA35) Impact of Staging 68Ga-PSMA-11 Pet Scans on Radiation Treatment Plans in Patients With Prostate Cancer International Journal of Radiation Oncology Biology Physics. 101. DOI: 10.1016/J.Ijrobp.2018.02.074 |
0.331 |
|
| 2017 |
Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, ... Nguyen H, et al. Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017742940. PMID 29185869 DOI: 10.1200/Jco.2017.74.2940 |
0.304 |
|
| 2017 |
Nguyen HG, Welty C, Lindquist K, Ngo V, Gilbert E, Bengtsson H, Magi-Galluzzi C, Jean-Gilles J, Yao J, Cooperberg M, Messing E, Klein EA, Carroll PR, Paris PL. Validation of GEMCaP as a DNA based biomarker to predict prostate cancer recurrence after radical prostatectomy. The Journal of Urology. PMID 28941923 DOI: 10.1016/J.Juro.2017.09.071 |
0.389 |
|
| 2017 |
Garcia-Reyes K, Nguyen HG, Zagoria RJ, Shinohara K, Carroll PR, Behr SC, Westphalen AC. Impact of lesion visibility on transrectal ultrasound on the prediction of clinically significant prostate cancer (Gleason score ≥ 3+4) with TRUS-MRI fusion biopsy. The Journal of Urology. PMID 28941918 DOI: 10.1016/J.Juro.2017.09.075 |
0.33 |
|
| 2017 |
Leapman MS, Cowan JE, Nguyen HG, Shinohara KK, Perez N, Cooperberg MR, Catalona WJ, Carroll PR. Active Surveillance in Younger Men With Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016680058. PMID 28346806 DOI: 10.1200/Jco.2016.68.0058 |
0.328 |
|
| 2017 |
Conn CS, Nguyen HG, Kye Y, Cunningham JT, Truillet C, Evans M, Huynh TL, Walters P, Ruggero D. Abstract A25: Sensing stress in cancer: a novel therapy targeting protein synthesis through the unfolded protein response in prostate cancer development Cancer Research. 77. DOI: 10.1158/1538-7445.Transcontrol16-A25 |
0.398 |
|
| 2017 |
Nguyen H, Shinohara K, Cowan J, Westphalen A, Cooperberg M, Simko J, Carroll P. Mp20-09 Evaluating Mri Fusion Biopsy Vs Systematic Ultrasound Guided Biopsy In Predicting High Grade Cancer At Time Of Radical Prostatectomy The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.641 |
0.337 |
|
| 2017 |
Nguyen H, Welty C, Lindquist K, Ngo V, Gilbert E, Bengtsson H, Magi-Galluzzi C, Jean Gilles J, Yao J, Cooperberg M, Messing E, Klein E, Carroll P, Paris P. PD71-05 VALIDATION OF GEMCAP AS A DNA BASED BIOMARKER TO PREDICT PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.3172 |
0.347 |
|
| 2017 |
Masic S, Washington S, Cowan J, Nguyen H, Shinohara K, Cooperberg M, Carroll P. Pd28-12 Effects Of Initial Gleason Grade On Outcomes During Active Surveillance For Prostate Cancer The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1246 |
0.361 |
|
| 2017 |
Boreta L, Xu M, Wu SY, Wu A, Nguyen H, Chang A, Roach M, Spratt DE, Feng FY, Carroll P, Hope T. Location of Recurrence by Gallium-68 PSMA PET Scan in Prostate Cancer Patients Eligible for Salvage Radiation Therapy International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.235 |
0.348 |
|
| 2017 |
Wu SY, Boreta L, Roach M, Feng FY, Wu A, Nguyen H, Hsu ICJ, Carroll P, Hope T, Chang AJ. Effect of Ga-68 PSMA PET Imaging on Radiation Treatment Plans for Prostate Cancer International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1260 |
0.336 |
|
| 2016 |
Tran GN, Leapman MS, Nguyen HG, Cowan JE, Shinohara K, Westphalen AC, Carroll PR. Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance. European Urology. PMID 27595378 DOI: 10.1016/J.Eururo.2016.08.023 |
0.363 |
|
| 2016 |
Leapman MS, Ameli N, Shinohara K, Nguyen HG, Meng MV, Cooperberg MR, Carroll PR. Validity of the Cancer of the Prostate Risk Assessment Score Derived From Targeted Biopsy: Modeling Evidence From Ultrasound Lesion-Directed Biopsy. Clinical Genitourinary Cancer. PMID 27522449 DOI: 10.1016/J.Clgc.2016.07.011 |
0.373 |
|
| 2016 |
Choi JY, Yang J, Noworolski SM, Behr S, Chang AJ, Simko JP, Nguyen HG, Carroll PR, Kurhanewicz J, Seo Y. (18)F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons. Radiology. 160220. PMID 27513849 DOI: 10.1148/Radiol.2016160220 |
0.342 |
|
| 2016 |
Leapman MS, Nguyen HG, Cooperberg MR. Clinical Utility of Biomarkers in Localized Prostate Cancer. Current Oncology Reports. 18: 30. PMID 27023445 DOI: 10.1007/S11912-016-0513-1 |
0.364 |
|
| 2016 |
Leapman M, Tran G, Nguyen H, Cowan J, Westphalen A, Shinohara K, Carroll P. MP15-19 FUSION MRI-ULTRASOUND BIOPSY DURING PROSTATE CANCER ACTIVE SURVEILLANCE Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2543 |
0.385 |
|
| 2016 |
Leapman M, Nguyen H, Cowan J, Perez N, Shinohara K, Catalona W, Cooperberg M, Carroll P. Pd03-01 Younger Age Is Associated With Decreased Risk Of Biopsy Progression During Active Surveillance For Low And Intermediate Risk Prostate Cancer The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2089 |
0.346 |
|
| 2016 |
Leapman M, Nguyen H, Cowan J, Porten S, Meng M, Cooperberg M, Carroll P. Mp80-01 Phosphodiesterase Type 5 Inhibitor Use Is Not Associated With Biochemical Recurrence After Definitive Therapy For Prostate Cancer The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2033 |
0.355 |
|
| 2015 |
Hsieh AC, Nguyen HG, Wen L, Edlind MP, Carroll PR, Kim W, Ruggero D. Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors. Science Signaling. 8: ra116. PMID 26577921 DOI: 10.1126/Scisignal.Aad5111 |
0.376 |
|
| 2015 |
Shi XB, Ma A, Xue L, Li M, Nguyen HG, Yang JC, Tepper CG, Gandour-Edwards R, Evans CP, Kung HJ, de Vere White RW. miR-124 and androgen receptor signaling inhibitors repress prostate cancer growth by downregulating androgen receptor splice variants, EZH2 and Src. Cancer Research. PMID 26573802 DOI: 10.1158/0008-5472.Can-14-0795 |
0.327 |
|
| 2015 |
Sheridan CM, Grogan TR, Nguyen HG, Galet C, Rettig MB, Hsieh AC, Ruggero D. YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence. Oncotarget. 6: 7470-80. PMID 25797255 DOI: 10.18632/Oncotarget.3477 |
0.419 |
|
| 2015 |
Nguyen HG, Welty CJ, Cooperberg MR. Diagnostic associations of gene expression signatures in prostate cancer tissue. Current Opinion in Urology. 25: 65-70. PMID 25405934 DOI: 10.1097/Mou.0000000000000131 |
0.4 |
|
| 2015 |
Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan JM, Meng MV, Simko JP, Cooperberg MR, Carroll PR. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer. The Journal of Urology. 193: 807-11. PMID 25261803 DOI: 10.1016/J.Juro.2014.09.094 |
0.387 |
|
| 2015 |
Tilki D, Hu B, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, et al. Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy. The Journal of Urology. 193: 436-42. PMID 25063493 DOI: 10.1016/J.Juro.2014.07.087 |
0.315 |
|
| 2014 |
Shinohara K, Nguyen H, Masic S. Management of an increasing prostate-specific antigen level after negative prostate biopsy. Urologic Clinics of North America. 41: 327-338. PMID 24725493 DOI: 10.1016/J.Ucl.2014.01.010 |
0.39 |
|
| 2014 |
Nguyen HG, Yang JC, Kung HJ, Shi XB, Tilki D, Lara PN, DeVere White RW, Gao AC, Evans CP. Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model. Oncogene. 33: 4521-30. PMID 24662833 DOI: 10.1038/Onc.2014.25 |
0.372 |
|
| 2014 |
Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Meng MV, Cooperberg MR, Carroll P. Factors associated with biopsy progression on active surveillance. Journal of Clinical Oncology. 32: 19-19. DOI: 10.1200/Jco.2014.32.4_Suppl.19 |
0.378 |
|
| 2014 |
Nguyen H, Cary C, Appa A, Cowan JE, Welty CJ, Roach M, Shinohara K, Carroll P. Outcomes after post-operative radiation therapy. Journal of Clinical Oncology. 32: 138-138. DOI: 10.1200/Jco.2014.32.4_Suppl.138 |
0.331 |
|
| 2014 |
Yang JC, Nguyen HG, Kung H, Shi X, Tilki D, White RWd, Gao AC, Evans CP. Abstract 327: Targeting autophagy overcomes enzalutamide resistance in castrate-resistant prostate cancer cells and improves therapeutic response in a xenograft model Cancer Research. 74: 327-327. DOI: 10.1158/1538-7445.Am2014-327 |
0.393 |
|
| 2014 |
Welty C, Cowan J, Nguyen H, Shinohara K, Perez N, Greene K, Meng M, Cooperberg M, Carroll P. Op3-03 Factors Associated With Biopsy Progression On Active Surveillance The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.2324 |
0.334 |
|
| 2013 |
Nguyen HG, Yang JC, Kung H, Gao AC, Evans CP. Abstract 1665: Autophagy is a survival mechanism in mediating resistance to androgen receptor signaling inhibitors in castrate resistant prostate cancer cells. Cancer Research. 73: 1665-1665. DOI: 10.1158/1538-7445.Am2013-1665 |
0.379 |
|
| 2013 |
Nguyen HG, Shi X, Xue L, Yang JC, Gao AC, Evans CP, DeVere White RW. 504 MICRORNA-124 SUPPRESSES PROSTATE TUMOR GROWTH BY DOWN-REGULATING THE EXPRESSION OF ANDROGEN RECEPTORS AND THEIR ALTERNATIVE SPLICE VARIANTS IN CWR22-RV1 IN-VIVO MODEL Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1898 |
0.355 |
|
| 2013 |
Nguyen HG, Yang JC, Hsing-Jien K, Gao AC, Evans CP. 503 AUTOPHAGY IS A SURVIVAL MECHANISM IN MEDIATING RESISTANCE TO ANDROGENT RECEPTOR SIGNALING INHIBITORS IN CASTRATE RESISTANT PROSTATE CANCER CELLS Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1897 |
0.349 |
|
| 2013 |
Yang J, Nguyen H, Gao A, Evans C. 317 ENHANCED IN VIVO INHIBITION OF NEUROPEPTIDE-MEDIATED CASTRATION RESISTANT PROSTATE CANCER PROGRESSION BY COMBINATION THERAPY WITH ENZALUTAMIDE AND SARACATINIB Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1702 |
0.363 |
|
| 2010 |
Nguyen HG, Ravid K. Polyploidy: mechanisms and cancer promotion in hematopoietic and other cells. Advances in Experimental Medicine and Biology. 676: 105-22. PMID 20687472 DOI: 10.1007/978-1-4419-6199-0_7 |
0.543 |
|
| 2009 |
Nguyen HG, Makitalo M, Yang D, Chinnappan D, St Hilaire C, Ravid K. Deregulated Aurora-B induced tetraploidy promotes tumorigenesis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 2741-8. PMID 19332642 DOI: 10.1096/Fj.09-130963 |
0.571 |
|
| 2008 |
Papadantonakis N, Makitalo M, McCrann DJ, Liu K, Nguyen HG, Martin G, Patel-Hett S, Italiano JE, Ravid K. Direct visualization of the endomitotic cell cycle in living megakaryocytes: differential patterns in low and high ploidy cells. Cell Cycle (Georgetown, Tex.). 7: 2352-6. PMID 18677109 DOI: 10.4161/Cc.6325 |
0.53 |
|
| 2008 |
McCrann DJ, Yezefski T, Nguyen HG, Papadantonakis N, Liu H, Wen Q, Crispino JD, Ravid K. Survivin overexpression alone does not alter megakaryocyte ploidy nor interfere with erythroid/megakaryocytic lineage development in transgenic mice. Blood. 111: 4092-5. PMID 18245663 DOI: 10.1182/Blood-2007-11-122150 |
0.549 |
|
| 2008 |
McCrann DJ, Nguyen HG, Jones MR, Ravid K. Vascular smooth muscle cell polyploidy: an adaptive or maladaptive response? Journal of Cellular Physiology. 215: 588-92. PMID 18181174 DOI: 10.1002/Jcp.21363 |
0.536 |
|
| 2007 |
Yang D, McCrann DJ, Nguyen H, St Hilaire C, DePinho RA, Jones MR, Ravid K. Increased polyploidy in aortic vascular smooth muscle cells during aging is marked by cellular senescence. Aging Cell. 6: 257-60. PMID 17291294 DOI: 10.1111/J.1474-9726.2007.00274.X |
0.544 |
|
| 2006 |
Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. The Journal of Clinical Investigation. 116: 1913-23. PMID 16823489 DOI: 10.1172/Jci27933 |
0.527 |
|
| 2006 |
Nguyen HG, Ravid K. Tetraploidy/aneuploidy and stem cells in cancer promotion: The role of chromosome passenger proteins. Journal of Cellular Physiology. 208: 12-22. PMID 16331679 DOI: 10.1002/Jcp.20565 |
0.584 |
|
| 2005 |
Nguyen HG, Chinnappan D, Urano T, Ravid K. Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting property. Molecular and Cellular Biology. 25: 4977-92. PMID 15923616 DOI: 10.1128/Mcb.25.12.4977-4992.2005 |
0.536 |
|
| 2005 |
Nguyen HG, Yu G, Makitalo M, Yang D, Xie HX, Jones MR, Ravid K. Conditional overexpression of transgenes in megakaryocytes and platelets in vivo. Blood. 106: 1559-64. PMID 15890684 DOI: 10.1182/Blood-2005-02-0638 |
0.54 |
|
| 2005 |
Nagata Y, Jones MR, Nguyen HG, McCrann DJ, St Hilaire C, Schreiber BM, Hashimoto A, Inagaki M, Earnshaw WC, Todokoro K, Ravid K. Vascular smooth muscle cell polyploidization involves changes in chromosome passenger proteins and an endomitotic cell cycle. Experimental Cell Research. 305: 277-91. PMID 15817153 DOI: 10.1016/J.Yexcr.2004.12.028 |
0.553 |
|
| 2004 |
Zhang Y, Nagata Y, Yu G, Nguyen HG, Jones MR, Toselli P, Jackson CW, Tatsuka M, Todokoro K, Ravid K. Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1-deregulated expression. Blood. 103: 3717-26. PMID 14751927 DOI: 10.1182/Blood-2003-09-3365 |
0.542 |
|
| 2004 |
Nguyen HG, Yu G, Makitalo M, Jones M, Ravid K. An Establishment of a System for Conditional Overexpression of Genes in Megakaryocytes and Platelets In Vivo. Blood. 104: 4196-4196. DOI: 10.1182/Blood.V104.11.4196.4196 |
0.531 |
|
| 2002 |
Kaluzhny Y, Hechler B, Lu J, Nguyen HG, Cataldo LM, Ravid K. A selective effect of Mpl ligand on mRNA stabilization during megakaryocyte differentiation. Febs Letters. 527: 279-83. PMID 12220674 DOI: 10.1016/S0014-5793(02)03230-1 |
0.699 |
|
| Show low-probability matches. |